盐酸埃克替尼是我国第一个表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)为靶点的靶向抗肿瘤药品,主要用于晚期肺癌的治疗。随着不断的临床实践,人们逐渐地从治疗晚期肺癌、化疗方案失败后的局部晚期或转移性非小细胞肺癌、晚期复发肺癌等应用到胃癌、肠癌等其它癌症患者,它也有显著的治疗效果,这引起广大医疗工作人员的兴趣。本文将最近几年埃克替尼的有关内容进行总结,供临床参考。 Icitinib hydrochloride is the first antitumor drug targeted by epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in China, which is mainly used for the treatment of advanced lung cancer. With continuous clinical practice, people gradually apply to the treatment of advanced lung cancer, local advanced or metastatic non-small cell lung cancer after the failure of chemotherapy regimen, advanced recurrent lung cancer and other cancer patients who have stomach cancer, colon cancer and other cancers, and also have remarkable treatment Effect, which aroused the interest of the majority of medical staff. This article summarizes the related contents of icotinil in recent years for clinical reference.